CSPC Pharmaceutical Group ( ($HK:1093) ) just unveiled an announcement. CSPC Pharmaceutical Group has received marketing approval from China’s ...
Investing.com -- CSPC Pharmaceutical has received approval from the U.S. Food and Drug Administration to conduct clinical trials for its recombinant fully human anti-ActRIIA/IIB monoclonal antibody ...
The latest announcement is out from CSPC Pharmaceutical Group ( ($HK:1093) ). CSPC Pharmaceutical Group Limited has received approval from the ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
The Hong Kong stock market turned lower again on Thursday, one day after ending the two-day slide in which it had tumbled more than ...
The National Finals of the 14th China Innovation and Entrepreneurship Competition Nanotechnology Innovation Professional ...
DelveInsight’s “Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 250+ Breast Cancer ...
CKH HOLDINGS 406,000 28,2 ...
Asia-Pacific equities ended mixed on Wednesday as investors assessed China’s latest inflation figures and awaited the US Federal Reserve’s final interest rate decision of the year. Markets broadly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback